Original articleResistance to antituberculosis drugs in Riyadh, Saudi Arabia
References (13)
- et al.
Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India
Tubercle
(1988) Drug resistant tuberculosis (Editorial)
Br Med J
(1981)National survey of tuberculosis notifications in England and Wales in 1983: Characteristics of Disease
Tubercle
(1987)Resistance to standard antituberculous drugs in Saudi Arabia
Saud Med J
(1986)- et al.
Evaluation of a rapid radiometric differentiation test for the Mycobacterium tuberculosis complex by selective inhibition with p-nitro-α-acetylamino-β-hydroxy-propiophenone
J Clin Microbiol
(1984) - et al.
Rapid drug-susceptibility testing of Mycobacterium tuberculosis
Am Rev Resp Dis
(1981)
Cited by (45)
A retrospective study of tuberculosis prevalence amongst patients attending a tertiary hospital in Riyadh, Saudi Arabia
2020, Journal of Clinical Tuberculosis and Other Mycobacterial DiseasesPrimary anti-tuberculous drugs resistance of pulmonary tuberculosis in Southwestern Saudi Arabia
2012, Journal of Infection and Public HealthCitation Excerpt :The prevalence of RIF resistance varied from 0.5% in Iceland to 22.7% in Azerbaijan in the GPADRS study [17], reaching 1.3%, 2.9% and 11.7% in Oman, Yemen and Jordan, respectively. The SPM and EMB resistance rates found in this study were lower than the SPM and EMB resistance rates reported in other Saudi studies [8–13]. In addition to the high overall drug resistance rate identified in this study, another important observation was the significant number of patients (18, 26.5%) with primary resistance to more than one drug.
First insight into the drug resistance pattern of Mycobacterium tuberculosis in Dohuk, Iraq: Using spoligotyping and MIRU-VNTR to characterize multidrug resistant strains
2011, Journal of Infection and Public HealthCitation Excerpt :In the present study, the most common drug resistance pattern INH resistance (12, 22.6%), followed by RMP resistance (10, 18.9%). In a study from Riyadh, the same resistance pattern was reported [22]. However, other resistance patterns have also been reported.
Tuberculosis in Saudi Arabia: Can we change the way we deal with the disease?
2010, Journal of Infection and Public HealthCitation Excerpt :There are several studies that have shown different rates of tuberculosis drug resistance across the country over the last 20 years (Table 4). However, these studies should be treated with caution for the following reasons: for some studies the methodologies were not clearly described, some are now out of date, the studies were retrospective, none followed the WHO guidelines for drug-resistance surveys and some studies are contradictory [3–6,11–14,16,18,26,27,29,38,39,41]. Existing committees should update the NTP guidelines for Saudi Arabia in accordance with World Health Organization (WHO) established guidelines.
Susceptibility pattern and epidemiology of Mycobacterium tuberculosis in a Saudi Arabian Hospital: A 15-year study from 1989 to 2003
2005, ChestCitation Excerpt :In Saudi Arabia, the resistance rates to isoniazid vary from one part of the country to another. In Riyadh, the resistance rates ranged from 4.2 to 7.2%.13,14 Similar rates of resistance of approximately 6% were reported in Dammam4 and Taif.15
Drug-resistant tuberculosis in Taipei, 1996-1999
2001, American Journal of Infection Control